IPO Lisboa FG, EPE /ID# 141938

Lisbon 1099-023

0 studies enrolling now · 1 studies all time

What they study most

Glioblastoma, Gliosarcoma

Studies at this site

• A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification — Completed